Conference
A Randomized, Double-Blind, Placebo Controlled Multicenter Study To Evaluate the Efficacy of a Humanized Interleukin-9 Monoclonal Antibody (MEDI-528) on the Late Asthmatic Response in Adults with Atopic Asthma.
Authors
Gauvreau G; Boulet L; Parker J; Sari S; White B; Molfino N; O'Byrne P
Publisher
American Thoracic Society
Publication Date
4 2009
DOI
10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a3639
Name of conference
B92. NEW TREATMENT APPROACHES FOR ASTHMA AND ALLERGY